Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

被引:18
|
作者
Wijarnpreecha, Karn [1 ,2 ,3 ]
Siri-Angkul, Natthaphat [1 ,2 ,3 ]
Shinlapawittayatorn, Krekwit [1 ,2 ,3 ]
Charoenkwan, Pimlak [3 ,4 ]
Silvilairat, Suchaya [3 ,4 ]
Siwasomboon, Chate [5 ]
Visarutratna, Pannee [5 ]
Srichairatanakool, Somdet [6 ]
Tantiworawit, Adisak [7 ]
Phrommintikul, Arintaya [7 ]
Chattipakorn, Siriporn C. [1 ,3 ,8 ]
Chattipakorn, Nipon [1 ,2 ,3 ]
机构
[1] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand
[3] Chiang Mai Univ, Ctr Excellence Cardiac Elect, Chiang Mai 50000, Thailand
[4] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50000, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai 50000, Thailand
[6] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50000, Thailand
[7] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand
[8] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand
来源
PLOS ONE | 2015年 / 10卷 / 06期
关键词
TRANSFERRIN-BOUND IRON; LABILE PLASMA IRON; OXIDATIVE STRESS; OVERLOAD CARDIOMYOPATHY; MAGNETIC-RESONANCE; CHELATION-THERAPY; SERUM FERRITIN; RISK; PATHOPHYSIOLOGY; METABOLISM;
D O I
10.1371/journal.pone.0130837
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Iron-overload cardiomyopathy is a major cause of death in thalassemia patients due to the lack of an early detection strategy. Although cardiac magnetic resonance (CMR) T2* is used for early detection of cardiac iron accumulation, its availability is limited. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and found to be depressed in thalassemia. However, its direct correlation with cardiac iron accumulation has never been investigated. We investigated whether HRV can be used as an alternative indicator for early identification of cardiac iron deposition in thalassemia patients. Methods Ninety-nine non-transfusion dependent thalassemia patients (23.00 (17.00, 32.75) years, 35 male) were enrolled. The correlation between HRV recorded using 24-hour Holter monitoring and non-transferrin bound iron (NTBI), hemoglobin (Hb), serum ferritin, LV ejection fraction (LVEF), and CMR-T2* were determined. Results The median NTBI value was 3.15 (1.11, 6.59) mu M. Both time and frequency domains of HRV showed a significant correlation with the NTBI level, supporting HRV as a marker of iron overload. Moreover, the LF/HF ratio showed a significant correlation with CMR-T2* with the receiver operating characteristic (ROC) curve of 0.684 +/- 0.063, suggesting that it could represent the cardiac iron deposit in thalassemia patients. HRV was also significantly correlated with serum ferritin and Hb. Conclusions This novel finding regarding the correlation between HRV and CMR-T2* indicates that HRV could be a potential marker in identifying early cardiac iron deposition prior to the development of LV dysfunction, and may be used as an alternative to CMR-T2* for screening cardiac iron status in thalassemia patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia
    Silvilairat, Suchaya
    Charoenkwan, Pimlak
    Saekho, Suwit
    Tantiworawit, Adisak
    Phrommintikul, Arintaya
    Srichairatanakool, Somdet
    Chattipakorn, Nipon
    PLOS ONE, 2016, 11 (10):
  • [2] Evaluation of cardiac complications in transfusion-dependent thalassemia (TDT) and non-transfusion dependent thalassemia (NTDT) beta thalassemia patients
    Nameq, Marah Sudad
    Shamoon, Rawand P.
    Saka, Mariwan H.
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (01) : 11 - 16
  • [3] Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
    Bou-Fakhredin, Rayan
    Bazarbachi, Abdul-Hamid
    Chaya, Bachar
    Sleiman, Joseph
    Cappellini, Maria Domenica
    Taher, Ali T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [4] Quality of Life in Patients with β-Thalassemia: Transfusion Dependent Versus Non-Transfusion Dependent
    Cappellini, Domenica
    Kattamis, Antonis
    Viprakasit, Vip
    Sutcharitchan, Pranee
    Mahmoud, Dalia
    Pariseau, Joseph
    Laadem, Abderrahmane
    Khan, Anzalee
    Hu, X. Henry
    Taher, Ali
    BLOOD, 2017, 130
  • [5] Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients
    Mona ElTagui
    Mona El-Ghamrawy
    Shareef Karam AlDeeb
    Mariam Saad Nassim
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 68 - 73
  • [6] Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients
    ElTagui, Mona
    El-Ghamrawy, Mona
    AlDeeb, Shareef Karam
    Nassim, Mariam Saad
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (01) : 68 - 73
  • [7] Oxidative Stress Damage of Iron Overload on Bone Marrow Erythropoiesis, Heart and Liver in Non-Transfusion Dependent Thalassemia
    Pan, Lin
    Xie, Yanni
    Yin, Xianqing
    Huang, Yumei
    Yang, Gaohui
    Li, Chan
    Chen, Yongyu
    Liu, Fengling
    Zhang, Ning
    Liang, Xiao
    Gan, Zhaoping
    Wei, Zhenbin
    Liang, Haiyan
    Liu, Qifa
    Lai, Yongrong
    Liu, Rongrong
    BLOOD, 2023, 142
  • [8] Phlebotomy and Hydroxyurea for Non-Transfusion Dependent Iron Overload in Beta-Thalassemia Intermedia
    Lahoud, Oscar Boutros
    Willis, Velta
    Solomon, William B.
    BLOOD, 2014, 124 (21)
  • [9] Deferasirox: an orphan drug for chronic iron overload in non-transfusion dependent thalassemia syndromes
    Halawi, Racha
    Motta, Irene
    Taher, Ali
    Cappellini, Maria Domenica
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 677 - 686
  • [10] Iron overload status in patients with non-transfusion-dependent thalassemia in China
    Huang, Yumei
    Yang, Gaohui
    Wang, Man
    Wei, Xiaoyun
    Pan, Lingyuan
    Liu, Jiaodi
    Lei, Yu
    Long, Liling
    Lai, Yongrong
    Liu, Rongrong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13